Dose-dependent effects of aficamten vs metoprolol in MAPLE-HCM

11 May 2026 (16:06 - 16:18)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)

4 More presentations in this session

Presentation thumbnail

sTTR variability and outcomes in ATTR-CM

Doctor S. Selvaraj (Durham, US)

Presentation thumbnail

BHB/HRS-1893 in non-obstructive hypertrophic cardiomyopathy

Doctor L. Wang (Beijing, CN)

Presentation thumbnail

RESOLVE-HCM: perhexiline on regression of LVH in symptomatic HCM

Professor J. Selvanayagam (Adelaide, AU)

Presentation thumbnail

ATTRibute-CM: outpatient worsening heart failure in ATTR-CM

Professor M. Fontana (London, GB)

Access the full session

Session thumbnail

Advances in cardiomyopathies

The Event

Event poster

Heart Failure 2026

11 May 2026 16:06 CET

You may be interested in

Congress Presentation

MAPLE-HCM: aficamten vs metoprolol in oHCM

Congress Presentation

Effect of Aficamten Compared with Metoprolol on Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy: A pre-specified analysis of MAPLE-HCM

Congress Presentation

Effects of bisoprolol and verapamil in non-obstructive hypertrophic cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources